Genetika člověka
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Pipetovací špičky
Plasty pro buněčnou kultivaci
Systém pro dlouhodobé skladování vzorků
Zkumavky
Třepačky
Suché lázně
Centrifugy
End Point cyclery
Real-time PCR cyclery
Fluorometry
Spektrofotometry
Izolátory nukleových kyselin
Pipetovací roboty
Biobanking
Live Cell Imaging
Jednokanálové
Multikanálové
Sérologické pipety
Jednorázové pipety
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Biochemie
Imunoanalýza
PIK3CA (Human) CRISPR Knockout HCT116 Cell Line – T2-3
| Unit |
1×10⁶ cells / 1.0 ml |
|---|---|
| Cell Type |
Stable (KO/Expressing) Cells |
| Tissue Type |
Colon |
| Organism |
Human (H. sapiens) |
| Donor History |
Male ,58 ,Caucasian ,Colorectal carcinoma |
| Growth Properties |
Adherent ,epithelial |
| Growth Conditions |
PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. Dulbecco's Modified Eagle Medium (DMEM) ,High Glucose (TM500) + 10% FBS + 1% Penicillin/Streptomycin Solution (G255) ,37.0°C ,5% CO₂. 0.4 µg/ml Puromycin (G264) for selection. Note: Selection drugs should be added to the culture medium after the first passage to ensure cells have recovered from freeze-thaw conditions. |
| Immortalization Method | |
| Full Information |
https://www.abmgood.com/PIK3CA-Human-CRISPR-Knockout-HCT116-Cell-Line-T2-3-T9835.html |
The PIK3CA (Human) CRISPR Knockout HCT116 Cell Line – T2-3 represents a powerful tool for cancer research, specifically focusing on the role of the PIK3CA gene in colorectal cancer. By utilizing CRISPR-Cas9 technology to knockout the PIK3CA gene in the HCT116 colorectal cancer cell line, this model offers an unprecedented opportunity to study the effects of PIK3CA deletion on cancer cell growth, survival, and response to therapies. PIK3CA, a critical component of the PI3K/AKT signaling pathway, is frequently mutated in various cancers, making its study essential for understanding tumorigenesis and developing targeted treatments. This cell line enables researchers to dissect the biological consequences of PIK3CA loss, investigate compensatory pathways that may be activated in its absence, and screen for drugs that effectively target PIK3CA-deficient tumors. This cell line is invaluable for advancing our knowledge of cancer biology and paving the way for novel therapeutic strategies.
